Candel Therapeutics (CADL) Return on Assets (2021 - 2025)

Candel Therapeutics (CADL) has 5 years of Return on Assets data on file, last reported at 0.01% in Q4 2025.

• For the quarter ending Q4 2025, Return on Assets changed 0.0% year-over-year to 0.01%; the trailing twelve-month figure through Dec 2025 stood at 0.01% (changed 0.0% YoY), and the FY2025 full-year result was 0.01%, changed 0.0% from the prior year.
• Return on Assets was little changed at 0.01% in Q4 2025, from 0.01% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2021 to a low of 0.03% in Q3 2024.
• A 5-year average of 0.01% and a median of 0.01% in 2022 frame the typical range for Return on Assets.
• Across the five-year window, Return on Assets slipped 2 bps in 2024 and grew 2 bps in 2025, its largest moves.
• Tracing CADL's Return on Assets over 5 years: stood at 0.0% in 2021, then slumped by 68 bps to 0.01% in 2022, then slumped by 37 bps to 0.01% in 2023, then retreated by 1 bps to 0.01% in 2024, then soared by 32 bps to 0.01% in 2025.
• Business Quant data shows CADL's Return on Assets at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.